BusinessGeoVax Publishes Ebola Vaccine Study Results in Nature’s Scientific ReportsBy Nasdaq OMXJan 16, 2018, 2:00 PM UTC
BusinessAbCellera Announces Successful Completion of Collaboration for the Discovery of Fully Human Antibodies Against Pathogenic E. Coli and Ebola VirusBy Nasdaq OMXJan 21, 2016, 12:14 AM UTC
